Site map | Privacy Policy | 酒悶嶄猟井
  Home About Us Services News & Events Quality Assurance Career Contact Us  

Services

 
 

Services

Testing Capabilities

Pathology
• Cytopathology
• Histopathology
• Molecular Pathology

Clinical Trials & CRO
• Regulatory Affairs
• Project Management
• Central Lab
• DM & Statistics

 
Pathology >>> Molecular Pathology
 

In situ hybridization (ISH) and Fluorescence in situ hybridization (FISH)
ISH is broadly used in detecting DNA or RNA in pathologic tissues, its visualized methods frequently used today are nonradioactive or fluorochrome labeling the probe (FISH). ISH or FISH has its advantages in that on one side we may observe the gene changes occurring in tissues directly, such as HPV in cervical disease, EBV in lymphoma and nasopharyngeal carcinoma; on the other side we may detect a gene amplification in a tumor such as CerbB-2 in breast carcinoma and gastric adenocarcinoma, EGFR in non-small cell lung carcinoma, MDM2 in dedifferentiate liposarcoma. A standardized laboratory and process for ISH or FISH should be introduced to guarantee a highly duplication and reliability of the results.


ISH present EBER positivity in a peripheral T cell lymphoma

ISH shows EBER positivity in a EB associated leomyosarcoma

FISH shows Her2 amplification (red) in a breast invasive ductular carcinoma

CISH shows Her2 amplification in a gastric adenocarcinoma

Polymerase chain reaction (PCR) Technique
PCR technique is greatly attractive in surgical pathology in that it can be utilized to analyze DNA and RNA from samples of formalin-fixed, paraffin-embedded materials. Up to now, the PCR in our Department is used for various aims such as for detecting Immunoglobulin (Ig) or T cell receptor (TCR) gene rearrangements to determine the clonality of B- or T cell proliferations, for exposing chromosomal translocations occurred in hematologic malignancies (e.g., t(14;18) in follicular lymphoma); for discerning the point mutations in oncogenes and tumor-suppressor genes (e.g., activated RAS oncogenes in pancreatic carcinomas and EGFR mutation in non-small cell lung carcinoma); for identifying gene amplification (e.g., MYCN in neuroblastoma and HER2 in breast carcinoma); for showing microsatellite instability in gastrointestinal tumor and gene hypermethylation in various tumors.


A principle of PCR technique

T cell receiptorgene rearrangement from a peripheral T cell lymphoma

Immunoglobulin heavy chain variable gene (Fr3) rearrangement in a chronic lymphatic leikemia

EWS-FL1 gene rearrangement in a Ewings in a synovial sarcoma
 
 

Copyright 2008-2024 Shanghai Fenglin Clinical Laboratory All Rights Reserved

Address: 2F, Building 4, 188, Pingfu Road, Xuhui District, Shanghai 200231, P.R. China
Tel: (86) 21 3367 2666, 400 820 8668 Fax: (86) 21 3367 6446 Email: Marketing@scrcnet.org

Shanghai ICP 16030690-1